Home Featured Page 225

Featured

Latest

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

Dylan Beynon – Mindbloom – At Home Ketamine

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Genetic Determinants of the LSD Response

PTSF67 – Psilocybin, Power, and Patents

Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio

MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company

Reset Pharmaceuticals Enters into Exclusive Worldwide License Agreement with NYU Langone...

Awakn Establishes Separate Preclinical and Clinical Expert Advisory Boards to Optimize...

Q & A with Keeno Ahmed-Jones: Dismantling the Echo Chamber of...

Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved...

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary...

Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative...

1...224225226...292 Page 225 of 292

EDITOR PICKS

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

Dylan Beynon – Mindbloom – At Home Ketamine

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Genetic Determinants of the LSD Response

PTSF67 – Psilocybin, Power, and Patents

Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio

MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company

Reset Pharmaceuticals Enters into Exclusive Worldwide License Agreement with NYU Langone...

Awakn Establishes Separate Preclinical and Clinical Expert Advisory Boards to Optimize...

Q & A with Keeno Ahmed-Jones: Dismantling the Echo Chamber of...

Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved...

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary...

Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative...

EDITOR PICKS

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY